2011 Biotechnology Engineering Marketing 
Harvard Business Review
SEPTEMBER 11, 2014
That means new technologies and new competitors are hitting the market at an unprecedented rate. In fact, among the top 10 companies of the Forbes Most Innovative Companies list (since 2011 when we started the list), more than 80% of the most innovative companies compete in industries in the top right quadrant.
Harvard Business Review
MARCH 2, 2012
As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. has become a Mecca for international scientists, engineers and business students — particularly those undertaking graduate studies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
SEPTEMBER 14, 2011
In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. and the U.K.
Harvard Business Review
JUNE 16, 2016
To understand the nature of the problem, let’s look at how penicillin was brought to market. The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. Profit-driven companies, on the other hand, feel so much pressure to go to market that they often pass on ideas with vast potential.
Harvard Business Review
MARCH 5, 2012
Thus, the decline of manufacturing is not completely a result of "natural" market forces. And one look at the trade deficit ($558 billion in 2011) clearly indicates we don't have as much as our foreign competitors to sell in return. Production engineering is hard to do without a factory (it's like being a cook without a kitchen).
Expert insights. Personalized for you.
22 
Let's personalize your content